Advances in IL-17A Inhibitor Development for Immune-Mediated Diseases Shanghai Pharmaceuticals Holding Co. Ltd. is actively expanding its immunology pipeline, focusing on the development of interleukin-17A (IL-17A) inhibitors to treat chronic …
Tag: